Reloxaliase Uses, Dosage, Side Effects and more
Reloxaliase is under investigation in clinical trial NCT03456830 (Evaluate ALLN-177 in Patients With Enteric Hyperoxaluria).
| Attribute | Details |
|---|---|
| Trade Name | Reloxaliase |
| Generic | Reloxaliase |
| Reloxaliase Other Names | Reloxaliase |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
